373 related articles for article (PubMed ID: 17586744)
1. Coverage of postprandial blood glucose excursions with inhaled technosphere insulin in comparison to subcutaneously injected regular human insulin in subjects with type 2 diabetes.
Rave K; Heise T; Pfützner A; Boss AH
Diabetes Care; 2007 Sep; 30(9):2307-8. PubMed ID: 17586744
[No Abstract] [Full Text] [Related]
2. A review of inhaled technosphere insulin.
Neumiller JJ; Campbell RK; Wood LD
Ann Pharmacother; 2010; 44(7-8):1231-9. PubMed ID: 20516362
[TBL] [Abstract][Full Text] [Related]
3. Reduced postprandial glycaemic excursion with biphasic insulin Aspart 30 injected immediately before a meal.
Kapitza C; Rave K; Ostrowski K; Heise T; Heinemann L
Diabet Med; 2004 May; 21(5):500-1. PubMed ID: 15089801
[No Abstract] [Full Text] [Related]
4. [Lispro mixed insulins in type 2 diabetes. Preventing postprandial insulin rise].
MMW Fortschr Med; 2000 Jul; 142(28-29):58-9. PubMed ID: 10959169
[No Abstract] [Full Text] [Related]
5. Inhaled insulin for diabetes mellitus.
McMahon GT; Arky RA
N Engl J Med; 2007 Feb; 356(5):497-502. PubMed ID: 17267909
[No Abstract] [Full Text] [Related]
6. [Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies].
Sjöholm A
Lakartidningen; 2001 Feb; 98(9):937-40. PubMed ID: 11292972
[TBL] [Abstract][Full Text] [Related]
7. Clinical update on Humalog Mix25 a novel pre-mixed formulation of insulin lispro and NPL.
Herz M
Int J Clin Pract Suppl; 1999 Jul; 104():8-13; discussion 18-20. PubMed ID: 12669732
[No Abstract] [Full Text] [Related]
8. [Performance of real-world studies for inhaled insulin].
Göke B
Dtsch Med Wochenschr; 2005 Jul; 130 Suppl 2():S91-4. PubMed ID: 15988676
[No Abstract] [Full Text] [Related]
9. Optimal dose and timing of insulin Aspart to mimic first phase insulin response in patients with recently onset type 2 diabetes.
Gredal C; Rosenfalck A; Dejgaard A; Hilsted J
Diabetes Res Clin Pract; 2008 May; 80(2):293-8. PubMed ID: 18304675
[TBL] [Abstract][Full Text] [Related]
10. [Insulin to be inhaled soon].
MMW Fortschr Med; 2005 Sep; 147(35-36):5. PubMed ID: 16180561
[No Abstract] [Full Text] [Related]
11. Defining the role of incretin mimetic therapy in the management of type 2 diabetes.
Unger J; Nadeau DA
J Fam Pract; 2007 Dec; 56(12 Suppl New):S4-S10. PubMed ID: 18664341
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of post-prandial blood glucose excursions in type 1 and type 2 diabetes mellitus.
Slama G
Int J Clin Pract Suppl; 2000 Sep; (112):9-12. PubMed ID: 11064945
[No Abstract] [Full Text] [Related]
13. Pulmonary insulin delivery by means of the Technosphere drug carrier mechanism.
Pfützner A; Forst T
Expert Opin Drug Deliv; 2005 Nov; 2(6):1097-106. PubMed ID: 16296812
[TBL] [Abstract][Full Text] [Related]
14. Type 2 diabetes - controlling hyperglycaemia with early insulin use.
MacIsaac R; Cheung A; Jerums G
Aust Fam Physician; 2010 Aug; 39(8):565-9. PubMed ID: 20877750
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes.
Cervera A; Wajcberg E; Sriwijitkamol A; Fernandez M; Zuo P; Triplitt C; Musi N; DeFronzo RA; Cersosimo E
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E846-52. PubMed ID: 18334612
[TBL] [Abstract][Full Text] [Related]
16. [Treating hyperglycemia of type 2 diabetes with intravenous insulin infusion].
Vanamo R
Duodecim; 1997; 113(5):423-7. PubMed ID: 11370085
[No Abstract] [Full Text] [Related]
17. Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes.
Linnebjerg H; Park S; Kothare PA; Trautmann ME; Mace K; Fineman M; Wilding I; Nauck M; Horowitz M
Regul Pept; 2008 Nov; 151(1-3):123-9. PubMed ID: 18675854
[TBL] [Abstract][Full Text] [Related]
18. Targeting postprandial hyperglycaemia in patients with recently diagnosed type 2 diabetes with a fixed, weight-based dose of insulin Aspart.
Gredal C; Rosenfalck AM; Dejgaard A; Hilsted J
Scand J Clin Lab Invest; 2008; 68(8):739-44. PubMed ID: 19016075
[TBL] [Abstract][Full Text] [Related]
19. Postprandial hyperglycemia is associated with an increase of blood pressure in type 1 diabetic patients treated with continuous subcutaneous insulin infusion.
Lepore G; Corsi A; Dodesini AR; Nosari I; Trevisan R
Diabetes Care; 2007 Jul; 30(7):e60. PubMed ID: 17596483
[No Abstract] [Full Text] [Related]
20. Curbside consultation. Why can't this patient take insulin?
Nymberg JH; Selby JW
Am Fam Physician; 2000 Jan; 61(1):226, 228, 231. PubMed ID: 10643960
[No Abstract] [Full Text] [Related]
[Next] [New Search]
